TrialJACC. Heart failure2024

Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial.

Senthil Selvaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.